Mild hypertension. When and how to treat

Norman M Kaplan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

'Early and aggressive' drug therapy for mild hypertension, now widely prescribed in the United States, may be inappropriate for many of the 30 million patients with this condition. Although all of these patients are at greater risk of premature cardiovascular disease, the risks are manifested neither quickly nor uniformly. Drug therapy has not proved beneficial for patients with a diastolic (D) BP reading below 100 mm Hg, particularly those patients who are otherwise at low risk. Those antihypertensive drugs that are available now carry risks along with their benefits. Therefore, persons with mild hypertension who are at low risk should be encouraged to use nondrug therapies for at least six to 12 months. If their DBP remains below 100 mm Hg, they may be better off than if they were given drugs. The drug used in initial therapy has usually been a diuretic. For many patients, however, an adrenergic inhibitor may be a more appropriate choice.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalArchives of Internal Medicine
Volume143
Issue number2
DOIs
StatePublished - 1983

Fingerprint

Hypertension
Drug Therapy
Diuretics
Pharmaceutical Preparations
Adrenergic Agents
Antihypertensive Agents
Reading
Cardiovascular Diseases
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Mild hypertension. When and how to treat. / Kaplan, Norman M.

In: Archives of Internal Medicine, Vol. 143, No. 2, 1983, p. 255-259.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Mild hypertension. When and how to treat. In: Archives of Internal Medicine. 1983 ; Vol. 143, No. 2. pp. 255-259.
@article{d35f2b8ddeee428b9db136db8261c0d6,
title = "Mild hypertension. When and how to treat",
abstract = "'Early and aggressive' drug therapy for mild hypertension, now widely prescribed in the United States, may be inappropriate for many of the 30 million patients with this condition. Although all of these patients are at greater risk of premature cardiovascular disease, the risks are manifested neither quickly nor uniformly. Drug therapy has not proved beneficial for patients with a diastolic (D) BP reading below 100 mm Hg, particularly those patients who are otherwise at low risk. Those antihypertensive drugs that are available now carry risks along with their benefits. Therefore, persons with mild hypertension who are at low risk should be encouraged to use nondrug therapies for at least six to 12 months. If their DBP remains below 100 mm Hg, they may be better off than if they were given drugs. The drug used in initial therapy has usually been a diuretic. For many patients, however, an adrenergic inhibitor may be a more appropriate choice.",
author = "Kaplan, {Norman M}",
year = "1983",
doi = "10.1001/archinte.143.2.255",
language = "English (US)",
volume = "143",
pages = "255--259",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Mild hypertension. When and how to treat

AU - Kaplan, Norman M

PY - 1983

Y1 - 1983

N2 - 'Early and aggressive' drug therapy for mild hypertension, now widely prescribed in the United States, may be inappropriate for many of the 30 million patients with this condition. Although all of these patients are at greater risk of premature cardiovascular disease, the risks are manifested neither quickly nor uniformly. Drug therapy has not proved beneficial for patients with a diastolic (D) BP reading below 100 mm Hg, particularly those patients who are otherwise at low risk. Those antihypertensive drugs that are available now carry risks along with their benefits. Therefore, persons with mild hypertension who are at low risk should be encouraged to use nondrug therapies for at least six to 12 months. If their DBP remains below 100 mm Hg, they may be better off than if they were given drugs. The drug used in initial therapy has usually been a diuretic. For many patients, however, an adrenergic inhibitor may be a more appropriate choice.

AB - 'Early and aggressive' drug therapy for mild hypertension, now widely prescribed in the United States, may be inappropriate for many of the 30 million patients with this condition. Although all of these patients are at greater risk of premature cardiovascular disease, the risks are manifested neither quickly nor uniformly. Drug therapy has not proved beneficial for patients with a diastolic (D) BP reading below 100 mm Hg, particularly those patients who are otherwise at low risk. Those antihypertensive drugs that are available now carry risks along with their benefits. Therefore, persons with mild hypertension who are at low risk should be encouraged to use nondrug therapies for at least six to 12 months. If their DBP remains below 100 mm Hg, they may be better off than if they were given drugs. The drug used in initial therapy has usually been a diuretic. For many patients, however, an adrenergic inhibitor may be a more appropriate choice.

UR - http://www.scopus.com/inward/record.url?scp=0020686510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020686510&partnerID=8YFLogxK

U2 - 10.1001/archinte.143.2.255

DO - 10.1001/archinte.143.2.255

M3 - Article

C2 - 6130750

AN - SCOPUS:0020686510

VL - 143

SP - 255

EP - 259

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 2

ER -